Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

REDD1 Activates a ROS-Generating Feedback Loop in the Retina of Diabetic Mice.

Miller WP, Toro AL, Barber AJ, Dennis MD.

Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2369-2379. doi: 10.1167/iovs.19-26606.

2.

Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy.

Orchard PJ, Markowski TW, Higgins L, Raymond GV, Nascene DR, Miller WP, Pierpont EI, Lund TC.

Sci Rep. 2019 May 27;9(1):7858. doi: 10.1038/s41598-019-44140-3.

3.

Biochemical and clinical response after umbilical cord blood transplant in a boy with early childhood-onset beta-mannosidosis.

Lund TC, Miller WP, Eisengart JB, Simmons K, Pollard L, Renaud DL, Wenger DA, Patterson MC, Orchard PJ.

Mol Genet Genomic Med. 2019 May 21:e712. doi: 10.1002/mgg3.712. [Epub ahead of print]

4.

Intrathecal enzyme replacement for Hurler syndrome: biomarker association with neurocognitive outcomes.

Eisengart JB, Pierpont EI, Kaizer AM, Rudser KD, King KE, Pasquali M, Polgreen LE, Dickson PI, Le SQ, Miller WP, Tolar J, Orchard PJ, Lund TC.

Genet Med. 2019 Apr 25. doi: 10.1038/s41436-019-0522-1. [Epub ahead of print]

PMID:
31019279
5.

O-GlcNAcylation alters the selection of mRNAs for translation and promotes 4E-BP1-dependent mitochondrial dysfunction in the retina.

Dierschke SK, Miller WP, Favate JS, Shah P, Imamura Kawasawa Y, Salzberg AC, Kimball SR, Jefferson LS, Dennis MD.

J Biol Chem. 2019 Apr 5;294(14):5508-5520. doi: 10.1074/jbc.RA119.007494. Epub 2019 Feb 7.

PMID:
30733333
6.

Successful donor engraftment and repair of the blood-brain barrier in cerebral adrenoleukodystrophy.

Orchard PJ, Nascene DR, Miller WP, Gupta A, Kenney-Jung D, Lund TC.

Blood. 2019 Mar 21;133(12):1378-1381. doi: 10.1182/blood-2018-11-887240. Epub 2019 Jan 11.

7.

Deletion of the stress-response protein REDD1 promotes ceramide-induced retinal cell death and JNK activation.

Dai W, Miller WP, Toro AL, Black AJ, Dierschke SK, Feehan RP, Kimball SR, Dennis MD.

FASEB J. 2018 Jun 19:fj201800413RR. doi: 10.1096/fj.201800413RR. [Epub ahead of print]

PMID:
29920218
8.

Post-transplant adaptive function in childhood cerebral adrenoleukodystrophy.

Pierpont EI, McCoy E, King KE, Ziegler RS, Shanley R, Nascene D, Raymond GV, Phelan R, Lund TC, Orchard PJ, Miller WP.

Ann Clin Transl Neurol. 2018 Jan 22;5(3):252-261. doi: 10.1002/acn3.526. eCollection 2018 Mar.

9.

Publisher Correction: Fast, sensitive method for trisaccharide biomarker detection in mucopolysaccharidosis type 1.

Makino E, Klodnitsky H, Leonard J, Lillie J, Lund TC, Marshall J, Nietupski J, Orchard PJ, Miller WP, Phaneuf C, Tietz D, Varban ML, Donovan M, Belenki A.

Sci Rep. 2018 Mar 19;8(1):4994. doi: 10.1038/s41598-018-23332-3.

10.

Fast, sensitive method for trisaccharide biomarker detection in mucopolysaccharidosis type 1.

Makino E, Klodnitsky H, Leonard J, Lillie J, Lund TC, Marshall J, Nietupski J, Orchard PJ, Miller WP, Phaneuf C, Tietz D, Varban ML, Donovan M, Belenki A.

Sci Rep. 2018 Feb 27;8(1):3681. doi: 10.1038/s41598-018-22078-2. Erratum in: Sci Rep. 2018 Mar 19;8(1):4994.

11.

Deletion of the Akt/mTORC1 Repressor REDD1 Prevents Visual Dysfunction in a Rodent Model of Type 1 Diabetes.

Miller WP, Yang C, Mihailescu ML, Moore JA, Dai W, Barber AJ, Dennis MD.

Diabetes. 2018 Jan;67(1):110-119. doi: 10.2337/db17-0728. Epub 2017 Oct 26.

12.

Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.

Eichler F, Duncan C, Musolino PL, Orchard PJ, De Oliveira S, Thrasher AJ, Armant M, Dansereau C, Lund TC, Miller WP, Raymond GV, Sankar R, Shah AJ, Sevin C, Gaspar HB, Gissen P, Amartino H, Bratkovic D, Smith NJC, Paker AM, Shamir E, O'Meara T, Davidson D, Aubourg P, Williams DA.

N Engl J Med. 2017 Oct 26;377(17):1630-1638. doi: 10.1056/NEJMoa1700554. Epub 2017 Oct 4.

13.

Quality of life among boys with adrenoleukodystrophy following hematopoietic stem cell transplant.

Beckmann NB, Miller WP, Dietrich MS, Orchard PJ.

Child Neuropsychol. 2018 Oct;24(7):986-998. doi: 10.1080/09297049.2017.1380176. Epub 2017 Sep 21.

PMID:
28934891
14.

Carpal boss syndrome: os styloideum fused to the trapezoid.

Nicolodi GC, Trippia CR, Caboclo MFFS, de Lima RR, Miller WP.

Radiol Bras. 2017 May-Jun;50(3):200-201. doi: 10.1590/0100-3984.2015.0160. No abstract available.

15.

Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group.

Wu CC, Econs MJ, DiMeglio LA, Insogna KL, Levine MA, Orchard PJ, Miller WP, Petryk A, Rush ET, Shoback DM, Ward LM, Polgreen LE.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3111-3123. doi: 10.1210/jc.2017-01127. Review.

PMID:
28655174
16.

The Frequency of Carpal Tunnel Syndrome in Hurler Syndrome After Peritransplant Enzyme Replacement Therapy: A Retrospective Comparison.

Wyffels ML, Orchard PJ, Shanley RM, Miller WP, Van Heest AE.

J Hand Surg Am. 2017 Jul;42(7):573.e1-573.e8. doi: 10.1016/j.jhsa.2017.03.036. Epub 2017 May 4.

PMID:
28479223
17.

Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.

Pierpont EI, Eisengart JB, Shanley R, Nascene D, Raymond GV, Shapiro EG, Ziegler RS, Orchard PJ, Miller WP.

JAMA Neurol. 2017 Jun 1;74(6):710-717. doi: 10.1001/jamaneurol.2017.0013.

18.

Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome.

Lum SH, Miller WP, Jones S, Poulton K, Ogden W, Lee H, Logan A, Bonney D, Lund TC, Orchard PJ, Wynn RF.

Bone Marrow Transplant. 2017 Jun;52(6):846-853. doi: 10.1038/bmt.2017.5. Epub 2017 Feb 20.

PMID:
28218755
19.

Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature.

Mallhi K, Orchard PJ, Miller WP, Cao Q, Tolar J, Lund TC.

Bone Marrow Transplant. 2017 May;52(5):726-732. doi: 10.1038/bmt.2016.356. Epub 2017 Jan 16.

20.

Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience.

Rodgers NJ, Kaizer AM, Miller WP, Rudser KD, Orchard PJ, Braunlin EA.

J Inherit Metab Dis. 2017 Mar;40(2):271-280. doi: 10.1007/s10545-016-0006-2. Epub 2017 Jan 4.

PMID:
28054207
21.

Allele-Level HLA Matching Impacts Key Outcomes Following Umbilical Cord Blood Transplantation for Inherited Metabolic Disorders.

Mallhi KK, Smith AR, DeFor TE, Lund TC, Orchard PJ, Miller WP.

Biol Blood Marrow Transplant. 2017 Jan;23(1):119-125. doi: 10.1016/j.bbmt.2016.10.019. Epub 2016 Oct 29.

22.

Activation of the Stress Response Kinase JNK (c-Jun N-terminal Kinase) Attenuates Insulin Action in Retina through a p70S6K1-dependent Mechanism.

Miller WP, Ravi S, Martin TD, Kimball SR, Dennis MD.

J Biol Chem. 2017 Feb 3;292(5):1591-1602. doi: 10.1074/jbc.M116.760868. Epub 2016 Dec 13.

23.

Elevated cerebral spinal fluid biomarkers in children with mucopolysaccharidosis I-H.

Raymond GV, Pasquali M, Polgreen LE, Dickson PI, Miller WP, Orchard PJ, Lund TC.

Sci Rep. 2016 Dec 2;6:38305. doi: 10.1038/srep38305.

24.

Intestinal perforation by an ingested foreign body.

Nicolodi GC, Trippia CR, Caboclo MF, de Castro FG, Miller WP, de Lima RR, Tazima L, Geraldo J.

Radiol Bras. 2016 Sep-Oct;49(5):295-299.

25.

Haploidentical transplantation with post-transplant cyclophosphamide following reduced-intensity conditioning for osteopetrosis: outcomes in three children.

Bahr TL, Lund T, Sando NM, Orchard PJ, Miller WP.

Bone Marrow Transplant. 2016 Nov;51(11):1546-1548. doi: 10.1038/bmt.2016.180. Epub 2016 Jul 4. No abstract available.

PMID:
27376448
26.

Impact of Graft-Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Nonmalignant Disease.

Kudek MR, Shanley R, Zantek ND, McKenna DH, Smith AR, Miller WP.

Biol Blood Marrow Transplant. 2016 Nov;22(11):2019-2024. doi: 10.1016/j.bbmt.2016.07.019. Epub 2016 Aug 2.

27.

Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning.

Phelan R, Mann E, Napurski C, DeFor TE, Petryk A, Miller WP, Wagner JE, Verneris MR, Smith AR.

Bone Marrow Transplant. 2016 Oct;51(10):1369-1375. doi: 10.1038/bmt.2016.150. Epub 2016 Jun 6.

28.

Childhood Cerebral Adrenoleukodystrophy: MR Perfusion Measurements and Their Use in Predicting Clinical Outcome after Hematopoietic Stem Cell Transplantation.

McKinney AM, Benson J, Nascene DR, Eisengart J, Salmela MB, Loes DJ, Zhang L, Patel K, Raymond GV, Miller WP.

AJNR Am J Neuroradiol. 2016 Sep;37(9):1713-20. doi: 10.3174/ajnr.A4773. Epub 2016 Apr 14.

29.

Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy.

Thibert KA, Raymond GV, Tolar J, Miller WP, Orchard PJ, Lund TC.

Sci Rep. 2016 Apr 15;6:24579. doi: 10.1038/srep24579.

30.

The Translational Repressor 4E-BP1 Contributes to Diabetes-Induced Visual Dysfunction.

Miller WP, Mihailescu ML, Yang C, Barber AJ, Kimball SR, Jefferson LS, Dennis MD.

Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1327-37. doi: 10.1167/iovs.15-18719.

31.

Progression of Hip Dysplasia in Mucopolysaccharidosis Type I Hurler After Successful Hematopoietic Stem Cell Transplantation.

Langereis EJ, den Os MM, Breen C, Jones SA, Knaven OC, Mercer J, Miller WP, Kelly PM, Kennedy J, Ketterl TG, O'Meara A, Orchard PJ, Lund TC, van Rijn RR, Sakkers RJ, White KK, Wijburg FA.

J Bone Joint Surg Am. 2016 Mar 2;98(5):386-95. doi: 10.2106/JBJS.O.00601.

PMID:
26935461
32.

Management of Red Teeth in an International Patient with X-Linked Adrenoleukodystrophy.

Petrova E, Miller WP, Myers SL, Karp JM.

Pediatr Dent. 2015 Nov-Dec;37(7):550-3.

PMID:
26883615
33.

Glucosamine induces REDD1 to suppress insulin action in retinal Müller cells.

Moore JA, Miller WP, Dennis MD.

Cell Signal. 2016 May;28(5):384-390. doi: 10.1016/j.cellsig.2016.01.017. Epub 2016 Feb 4.

34.

Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients.

Miller WP, Mantovani LF, Muzic J, Rykken JB, Gawande RS, Lund TC, Shanley RM, Raymond GV, Orchard PJ, Nascene DR.

AJNR Am J Neuroradiol. 2016 Feb;37(2):367-72. doi: 10.3174/ajnr.A4500. Epub 2015 Oct 1.

35.

Cardiac QTc interval characteristics before and after hematopoietic stem cell transplantation: an analysis of 995 consecutive patients at a single center.

Miller WP, Shanley R, Dorostkar P.

Bone Marrow Transplant. 2015 Jul;50(7):954-60. doi: 10.1038/bmt.2015.64. Epub 2015 Mar 30.

36.

Outcomes after hematopoietic stem cell transplantation for children with I-cell disease.

Lund TC, Cathey SS, Miller WP, Eapen M, Andreansky M, Dvorak CC, Davis JH, Dalal JD, Devine SM, Eames GM, Ferguson WS, Giller RH, He W, Kurtzberg J, Krance R, Katsanis E, Lewis VA, Sahdev I, Orchard PJ.

Biol Blood Marrow Transplant. 2014 Nov;20(11):1847-51. doi: 10.1016/j.bbmt.2014.06.019. Epub 2014 Jul 10.

37.

Comparison of hypersensitivity reactions to PEG-asparaginase in children after intravenous and intramuscular administration.

August KJ, Miller WP, Dalton A, Shinnick S.

J Pediatr Hematol Oncol. 2013 Oct;35(7):e283-6. doi: 10.1097/MPH.0b013e31828e5471.

PMID:
23619117
38.

IL-8 but not other biomarkers of endothelial damage is associated with disease activity in patients with ankylosing spondylitis without treatment with anti-TNF agents.

Azevedo VF, Faria-Neto JR, Stinghen A, Lorencetti PG, Miller WP, Gonçalves BP, Szyhta CC, Pecoits-Filho R.

Rheumatol Int. 2013 Jul;33(7):1779-83. doi: 10.1007/s00296-012-2631-x. Epub 2013 Jan 8.

PMID:
23297014
39.

Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction.

Thibert KA, Raymond GV, Nascene DR, Miller WP, Tolar J, Orchard PJ, Lund TC.

PLoS One. 2012;7(11):e50430. doi: 10.1371/journal.pone.0050430. Epub 2012 Nov 21.

40.

Childhood cerebral X-linked adrenoleukodystrophy: diffusion tensor imaging measurements for prediction of clinical outcome after hematopoietic stem cell transplantation.

McKinney AM, Nascene D, Miller WP, Eisengart J, Loes D, Benson M, Tolar J, Orchard PJ, Ziegler RS, Zhang L, Provenzale J.

AJNR Am J Neuroradiol. 2013 Mar;34(3):641-9. doi: 10.3174/ajnr.A3232. Epub 2012 Aug 16.

41.

Elevated cerebral spinal fluid cytokine levels in boys with cerebral adrenoleukodystrophy correlates with MRI severity.

Lund TC, Stadem PS, Panoskaltsis-Mortari A, Raymond G, Miller WP, Tolar J, Orchard PJ.

PLoS One. 2012;7(2):e32218. doi: 10.1371/journal.pone.0032218. Epub 2012 Feb 16.

42.

Arsenic in soils and forages from poultry litter-amended pastures.

Ashjaei S, Miller WP, Cabrera ML, Hassan SM.

Int J Environ Res Public Health. 2011 May;8(5):1534-46. doi: 10.3390/ijerph8051534. Epub 2011 May 12.

43.

Release of nitrogen and phosphorus from poultry litter amended with acidified biochar.

Doydora SA, Cabrera ML, Das KC, Gaskin JW, Sonon LS, Miller WP.

Int J Environ Res Public Health. 2011 May;8(5):1491-502. doi: 10.3390/ijerph8051491. Epub 2011 May 11.

44.

Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report.

Miller WP, Rothman SM, Nascene D, Kivisto T, DeFor TE, Ziegler RS, Eisengart J, Leiser K, Raymond G, Lund TC, Tolar J, Orchard PJ.

Blood. 2011 Aug 18;118(7):1971-8. doi: 10.1182/blood-2011-01-329235. Epub 2011 May 17.

45.

Oxytetracycline Dynamics on Peach Leaves in Relation to Temperature, Sunlight, and Simulated Rain.

Christiano RSC, Reilly CC, Miller WP, Scherm H.

Plant Dis. 2010 Oct;94(10):1213-1218. doi: 10.1094/PDIS-04-10-0282.

PMID:
30743611
46.

GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppression.

Miller WP, Srinivasan S, Panoskaltsis-Mortari A, Singh K, Sen S, Hamby K, Deane T, Stempora L, Beus J, Turner A, Wheeler C, Anderson DC, Sharma P, Garcia A, Strobert E, Elder E, Crocker I, Crenshaw T, Penedo MC, Ward T, Song M, Horan J, Larsen CP, Blazar BR, Kean LS.

Blood. 2010 Dec 9;116(24):5403-18. doi: 10.1182/blood-2010-06-289272. Epub 2010 Sep 10.

47.

Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responses.

Anderson A, Martens CL, Hendrix R, Stempora LL, Miller WP, Hamby K, Russell M, Strobert E, Blazar BR, Pearson TC, Larsen CP, Kean LS.

Am J Transplant. 2008 Nov;8(11):2252-64. doi: 10.1111/j.1600-6143.2008.02376.x. Epub 2008 Sep 17.

48.

Bermudagrass sod growth and metal uptake in coal combustion by-product-amended media.

Schlossberg MJ, Vanags CP, Miller WP.

J Environ Qual. 2004 Mar-Apr;33(2):740-8.

PMID:
15074828
49.

Composition and element solubility of magnetic and non-magnetic fly ash fractions.

Kukier U, Ishak CF, Sumner ME, Miller WP.

Environ Pollut. 2003;123(2):255-66.

PMID:
12628204
50.

Long-term biosolids application effects on metal concentrations in soil and bermudagrass forage.

Gaskin JW, Brobst RB, Miller WP, Tollner EW.

J Environ Qual. 2003 Jan-Feb;32(1):146-52.

PMID:
12549553

Supplemental Content

Loading ...
Support Center